Viyash Scientific delivered exceptional financial performance in the June 2026 quarter, with consolidated net profit surging 107.07% to ₹65.87 crore compared to ₹31.81 crore in the corresponding quarter of the previous year. According to reports from Business Standard, this represents a significant improvement in the company's bottom-line performance during the quarter ended June 2026.
The company's sales revenue increased 19.54% to ₹946.36 crore in the quarter ended June 2026, up from ₹791.64 crore in the same period last year. As reported by Business Standard, this revenue growth demonstrates the company's ability to expand its business operations and market presence during the quarter.
Operating profit margin (OPM) improved to 18.85% in the June 2026 quarter compared to 15.00% in the corresponding quarter of the previous year. According to the financial data reported by Business Standard, this margin expansion indicates better operational efficiency and cost management during the quarter.
Profit before tax (PBT) increased 127% to ₹112.41 crore in the June 2026 quarter compared to ₹49.59 crore in the previous year quarter. Additionally, PBDT (Profit Before Depreciation and Tax) rose 66% to ₹174.18 crore from ₹105.18 crore in the corresponding quarter of the previous year. These figures, as reported by Business Standard, demonstrate strong operational performance across multiple profitability metrics.
